Investing Ideas
/
U.S. Top Stock Picks from Analysts

U.S. Top Stock Picks from Analysts

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1200

0 new

Companies which are more than 50% undervalued based on analyst price target.

1,200 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
MSTR MicroStrategy	US$327.56	-2.2%	406.8%	US$82.1b	US$520.84	PS178.2x	E51.7%	n/a	Software
ON ON Semiconductor	US$51.25	-2.1%	-36.6%	US$22.3b	US$78.63	PE12.4x	E14.3%	n/a	Semiconductors
BIIB Biogen	US$141.35	-1.8%	-41.3%	US$20.7b	US$224.64	PE12.8x	E10.3%	n/a	Pharmaceuticals & Biotech
EIX Edison International	US$50.09	-7.2%	-22.6%	US$19.8b	US$81.18	PE14.7x	E13.5%	6.6%	Utilities
FSLR First Solar	US$168.34	0.5%	11.1%	US$18.0b	US$267.53	PE14.4x	E24.2%	n/a	Semiconductors
SMMT Summit Therapeutics	US$20.11	-6.5%	346.9%	US$15.2b	US$33.08	PB33.9x	E38.9%	n/a	Pharmaceuticals & Biotech
MRNA Moderna	US$32.60	-17.3%	-62.7%	US$12.9b	US$62.32	PS2.5x	E20.0%	n/a	Pharmaceuticals & Biotech
BMRN BioMarin Pharmaceutical	US$63.93	0.9%	-27.7%	US$12.3b	US$96.86	PE37.8x	E24.1%	n/a	Pharmaceuticals & Biotech
FTAI FTAI Aviation	US$112.84	12.2%	109.4%	US$12.2b	US$185.51	PS7.5x	E53.8%	1.1%	Capital Goods
PCVX Vaxcyte	US$87.42	-1.0%	16.9%	US$11.1b	US$149.89	PB3.2x	E27.1%	n/a	Pharmaceuticals & Biotech
SRPT Sarepta Therapeutics	US$111.82	-1.7%	-11.9%	US$10.7b	US$184.91	PE87.7x	E29.9%	n/a	Pharmaceuticals & Biotech
VFS VinFast Auto	US$3.80	-2.6%	-27.6%	US$9.1b	US$6.33	PS6x	E0.006%	n/a	Automobiles
RVMD Revolution Medicines	US$42.19	-1.8%	38.6%	US$8.1b	US$73.29	PS10507.4x	E20.1%	n/a	Pharmaceuticals & Biotech
ASND Ascendis Pharma	US$120.87	-7.5%	-14.7%	US$7.5b	US$193.27	PS21.4x	E57.7%	n/a	Pharmaceuticals & Biotech
JAZZ Jazz Pharmaceuticals	US$120.29	-3.3%	-2.5%	US$7.3b	US$180.95	PE15.7x	E12.3%	n/a	Pharmaceuticals & Biotech
LEGN Legend Biotech	US$35.38	-7.1%	-42.0%	US$6.6b	US$79.83	PS12.5x	E56.5%	n/a	Pharmaceuticals & Biotech
CHRD Chord Energy	US$109.38	-2.7%	-29.9%	US$6.6b	US$166.81	PE7.1x	E-2.4%	9.3%	Energy
LNTH Lantheus Holdings	US$88.71	-4.1%	58.0%	US$6.3b	US$134.69	PE14.4x	E12.8%	n/a	Healthcare
BBIO BridgeBio Pharma	US$31.85	-6.9%	-7.6%	US$6.2b	US$49.49	PS27.6x	E42.0%	n/a	Pharmaceuticals & Biotech
ANF Abercrombie & Fitch	US$114.73	-3.9%	4.2%	US$5.8b	US$187.40	PE10.8x	E7.3%	0%	Retail
MARA MARA Holdings	US$16.77	-8.6%	-29.8%	US$5.7b	US$27.00	PE34.6x	E-35.1%	n/a	Software
CYTK Cytokinetics	US$42.76	-13.5%	-44.4%	US$5.4b	US$80.80	PS1567.7x	E39.8%	n/a	Pharmaceuticals & Biotech
CELH Celsius Holdings	US$22.41	-10.3%	-61.6%	US$5.2b	US$38.31	PE30.9x	E19.0%	n/a	Food, Beverage & Tobacco
IONS Ionis Pharmaceuticals	US$31.40	-1.6%	-38.9%	US$5.2b	US$61.32	PS6.2x	E40.4%	n/a	Pharmaceuticals & Biotech

Page 1 of 50